Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: With special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis

Histopathology

Volumn 56, Issue 3, 2010, Pages 384-394

  Enoki, Yasuyuki ^a   Katoh, Genichi ^a   Okabe, Hidetoshi ^b   Yanagisawa, Akio ^c  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Acquired cystic disease associated renal cell carcinoma; Calcium oxalate; CD57(HNK 1); Histogenesis; Loop of Henle

Indexed keywords

CALCIUM OXALATE; CD57 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HENLE LOOP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY POLYCYSTIC DISEASE; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD57; CALCIUM OXALATE; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; LOOP OF HENLE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RENAL DIALYSIS; TIME; TUMOR MARKERS, BIOLOGICAL;

EID: 77449116600     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03480.x     Document Type: Article

References (30)

1. Choyke PL. Acquired cystic kidney disease. Eur. Radiol. 2000 10 1716 1721 (Review).
2. Denton MD, Magee CC, Ovuworie C et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002 61 2201 2209.
3. Hughson MD, Schmidt L, Zbar B et al. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J. Am. Soc. Nephrol. 1996 7 2461 2468.
4. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993 22 135 139.
5. Peces R, Martinez-Ara J, Miguel JL et al. Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation. Nephrol. Dial. Transplant. 2004 19 2789 2796.
6. Sasagawa I, Nakada T, Kubota Y et al. Renal cell carcinoma in dialysis patients. Urol. Int. 1994 53 79 81.
7. Cossu-Rocca P, Eble JN, Zhang S et al. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod. Pathol. 2006 19 780 787.
8. Sule N, Yakupoglu U, Shen SS et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am. J. Surg. Pathol. 2005 29 443 451.
9. Tickoo SK, dePeralta-Venturina MN, Harik LR et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 2006 30 141 153.
10. Dry SM, Renshaw AA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases. Arch. Pathol. Lab. Med. 1998 122 260 261.
11. Rioux-Leclercq NC, Epstein JI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney. Arch. Pathol. Lab. Med. 2003 127 E89 E92.
12. Eble JN. WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs, 1st edn. Lyon : IARC Press, 2004 1 360.
13. Storkel S, Eble JN, Adlakha K et al. Classification of renal cell carcinoma: workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997 80 987 989.
14. Hughson MD, Hennigar GR, McManus JF. Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys. Lab. Invest. 1980 42 475 480.
15. Allory Y, Commo F, Boccon-Gibod L et al. Sulfated HNK-1 epitope in developing and mature kidney: a new marker for thin ascending loop of Henle and tubular injury in acute tubular necrosis. J. Histochem. Cytochem. 2006 54 575 584.
16. Murphy WM, Gringnon DJ, Perman EJ. AFIP atlas of tumor pathology, 4th series, Fascicle 1, Tumors of the kidney, bladder, and related urinary structures. Washington DC : American Registry of Pathology, 2004 101 109.
17. Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J. Clin. Pathol. 1977 30 868 877.
18. Ishikawa I. Uremic acquired renal cystic disease. Natural history and complications. Nephron 1991 58 257 267.
19. Ishikawa I, Saito Y, Asaka M et al. Twenty-year follow-up of acquired renal cystic disease. Clin. Nephrol. 2003 59 153 159.
20. Concolino G, Lubrano C, Ombres M et al. Acquired cystic kidney disease: the hormonal hypothesis. Urology 1993 41 170 175 (Review).
21. Matson MA, Cohen EP. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore) 1990 69 217 226.
22. Ikeda R, Tanaka T, Moriyama MT et al. Proliferative activity of renal cell carcinoma associated with acquired cystic disease of the kidney: comparison with typical renal cell carcinoma. Hum. Pathol. 2002 33 230 235.
23. Khurana KK, Truong LD, Verani RR et al. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Mod. Pathol. 1998 11 339 346.
24. Miyata Y, Koga S, Kanda S et al. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin. Cancer Res. 2003 9 1741 1749.
25. Hori Y, Oda Y, Kiyoshima K et al. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. J. Pathol. 2007 212 218 226.
26. Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic kidney disease. Am. J. Kidney Dis. 1995 26 1 12.
27. Chow WH, Lindbland P, Gridley G et al. Risk of urinary tract cancers following kidney or ureter stones. J. Natl Cancer Inst. 1997 89 1453 1457.
28. Evan AP, Lingeman JE, Coe FL et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J. Clin. Invest. 2003 111 607 616.
29. Jouret F, Igarashi T, Gofflot F et al. Comparative ontogeny, processing and segmental distribution of the renal chloride channel, CLC-5. Kidney Int. 2004 65 198 208.
30. Chen YT, Tu JJ, Kao J et al. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Clin. Cancer Res. 2005 11 6558 6566.